Form 8-K bluebird bio, Inc. For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
bluebird bio (BLUE) Misses Q3 EPS by 11c
November 12, 2014 7:21 AM ESTbluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($0.61), $0.11 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $6.2 million.
For earnings history and earnings-related data on bluebird bio (BLUE) click here.
... More


